Leiping Wang

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0002-0605-1621

发表论文 133 篇 · 总被引 2662 次 · h-index 24

代表论文

• Breast cancer: pathogenesis and treatments (2025 · Signal Transduction and Targeted Therapy · 被引 819)
• ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer (2025 · Signal Transduction and Targeted Therapy · 被引 29)
• ACE-Breast-02: A pivotal phase II/III trial of ARX788, a novel anti-HER2 antibody-drug conjugate (ADC), versus lapatinib plus capecitabine for HER2+ advanced breast cancer (ABC). (2024 · Journal of Clinical Oncology · 被引 13)
• In situ synthesis of porous metal-organic frameworks NH2-UiO-66 on tea stem biochar and application in odours adsorption (2024 · Environmental Pollution · 被引 11)
• Boosting photocatalytic desulfurization efficiency via in-situ Ti-MOF disassembly and reconstruction strategies on S-scheme M-TiO2@Cu2S heterojunction (2025 · Chemical Engineering Journal · 被引 7)
• Catalytic fixation of hydrogen sulfide over CuO-CaCO3 co-impregnated tea stalk-derived biochar (2024 · Journal of environmental chemical engineering · 被引 7)